Warner Chilcott Co., LLC v. Impax Laboratories, Inc.

U.S. Court of Appeals for the Federal Circuit

Warner Chilcott Co., LLC v. Impax Laboratories, Inc.

Opinion

NOTE: This order is nonprecedential

United States Court of Appeals for the Federal Circuit

WARNER CHILCOTT COMPANY, LLC, WARNER CHILCOTT (US), LLC, AND MAYNE PHARMA INTERNATIONAL PTY. LTD., Plaintiffs-Appellants,

V.

IMPAX LABORATORIES, INC., Defendant-Appellee,

AND

MYLAN PHARMACEUTICALS INC. AND MYLAN INC., Defendants-Appellees,

AND

SANDOZ, INC., Defendant-Appellee.

2012-1376, -1377, -1378

Appeals from the United States District Court for the District of New Jersey in consolidated case nos. OS-CV- 6304, 09-CV-l233, and 09-CV-2073, Judge William J. Martini.

ON MOTION

WARNER CHILCOTT COMPANY V. IMPAX LABORATORIES 2

Before NEWMAN, Circuit Judge. O R D E R

Warner Chilcott Company, LLC, Warner Chilcott (US), LLC, and Mayne Pharma International Pty. Ltd. move to expedite the briefing schedule and oral argument in these appeals. Impax Laboratories, Inc., Mylan Phar- maceuticals Inc. and Mylan lnc. oppose.

Upon consideration thereof, IT ls ORDERED THAT:

The motion is granted. Warner Chilcott’s brief is due on June 8, 2012. Irnpax and Mylan and Sandoz, Inc.’s briefs are due on July 13, 2012. Warner Chi1cott’s reply brief and the joint appendix are due on July 25, 2012. Oral argument will be scheduled by subsequent order.

FoR THE COURT

2 4 /s/ Jan Horbaly Date J an Horbaly Clerk cc: Dominick A. Conde, Esq. Michael E. Patunas, Esq. Larry L. Shatzer, III, Esq. F“_ED Eric l. Abraham, Esq. 05 823 HAY 2 4_2[]12 JAN HURBA\.Y

CLEH|(

Reference

Status
Unpublished